Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) presented new long-term safety data of plecanatide, its investigational, orally-administered compound currently being evaluated by ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE